ישראל - עברית - Ministry of Health

kamada ltd, israel - rupatadine as fumarate - תמיסה - rupatadine as fumarate 1 mg / 1 ml - rupatadine

ישראל - עברית - Ministry of Health

kamada ltd, israel - viable salmonella typhi ty21a cells - viable salmonella typhi ty21a cells

ישראל - עברית - Ministry of Health

kamada ltd, israel - prednisolone as sodium phosphate - תמיסה - prednisolone as sodium phosphate 1 mg/ml - prednisolone

ישראל - עברית - Ministry of Health

kamada ltd, israel - teriparatide - תמיסה להזרקה - teriparatide 0.250 mg / 1 ml - teriparatide

ישראל - עברית - Ministry of Health

kamada ltd, israel - pegfilgrastim - תמיסה להזרקה - pegfilgrastim 10 mg/ml - pegfilgrastim

ישראל - עברית - Ministry of Health

kamada ltd, israel - japanese encephalitis purified inactivated vaccine - תרחיף להזרקה - japanese encephalitis purified inactivated vaccine 6 au / 0.5 ml - encephalitis, japanese, inactivated, whole virus

ישראל - עברית - Ministry of Health

kamada ltd, israel - plasma protein fraction - תמיסה לאינפוזיה - plasma protein fraction 200 mg/ml - protein c - protein c - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendation.

ישראל - עברית - Ministry of Health

kamada ltd, israel - factor ix - אבקה להכנת תמיסה לזריקה - factor ix 1000 iu/vial - coagulation factor ix, ii, vii and x in combination - coagulation factor ix, ii, vii and x in combination - treatment and prophylaxis of bleeding in patients with haemophilia b ( congenital factor ix deficiency).

ישראל - עברית - Ministry of Health

kamada ltd, israel - human plasma coagulation factor viii - אבקה להכנת תמיסה לזריקה - human plasma coagulation factor viii 50 iu/ml - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding: in patients with haemophilia a (congenital factor viii deficiency) in patient with acquired factor viii deficiency. haemoctin is not effective in controlling the bleeding of patients with von willebrond`s disease.

ישראל - עברית - Ministry of Health

kamada ltd, israel - human plasma coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - human plasma coagulation factor viii 50 iu/ml - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding: in patients with haemophilia a (congenital factor viii deficiency) in patient with acquired factor viii deficiency.haemoctin is not effective in controlling the bleeding of patients with von willebrond`s disease.